TheraLode™
UN&UP’s TheraLode™ technology greatly improves thrombolysis by overcoming natural blood flow barriers preventing thrombolytic agents from reaching the clot, while accelerating clot lysis using 250X lower thrombolytic doses.
UN&UP’s TheraLode™ technology greatly improves thrombolysis by overcoming natural blood flow barriers preventing thrombolytic agents from reaching the clot, while accelerating clot lysis using 250X lower thrombolytic doses.